Simos Simeonidis

Simos Simeonidis

Plus aucun poste en cours
56 ans
Finance
Consumer Services
Health Technology

Profil

Simos Simeonidis is currently Managing Partner at Kos Biotechnology Partners LLC.
Former positions include Co-CEO & Co-CIO at Ally Bridge Group HK Ltd (2022–2023), Co-Chief Executive & Investment Officer at Ally Bridge Group (NY) LLC (2022–2023), Independent Director at Regulus Therapeutics, Inc. (2019–2022), Senior Managing Director & Partner at Sarissa Capital Acquisition Corp.
(2017–2021), Managing Director at Royal Bank of Canada (New York Branch) (2014–2017), Analyst at RBC Capital Markets LLC (2014–2017), Managing Director & Senior Biotech Analyst at Cowen & Co. LLC (2011–2014), Managing Director & Senior Biotech Analyst at Rodman & Renshaw LLC (2011), Vice President & Senior Biotech Analyst at Broadpoint.
Gleacher Securities (2007–2008), Associate Biotech Analyst at Morgan Stanley & Co. LLC (2006), Associate Director at Novartis Corp.
(2005), and Member at Harvard Medical School (2001–2003).
Education includes an undergraduate degree from Loyola University of Chicago (1993), an MBA from The Wharton School of the University of Pennsylvania (2005), and graduate and doctorate degrees from Columbia University College of Physicians & Surgeons.

Postes actifs de Simos Simeonidis

SociétésPosteDébut

Anciens postes connus de Simos Simeonidis

SociétésPosteFin
Directeur Général 01/01/2023
Directeur Général 01/01/2023
REGULUS THERAPEUTICS INC. Directeur/Membre du Conseil 06/12/2022
SARISSA CAPITAL ACQUISITION CORP. Corporate Officer/Principal 01/11/2021
Analyst-Equity 01/06/2017
Voir l'expérience en détail de Simos Simeonidis

Formation de Simos Simeonidis

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

93

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées15

Finance

Health Technology

Finance

Finance

Finance

Consumer Services

Finance

Finance

Health Technology

Consumer Services

Consumer Services

Consumer Services

Finance

Finance

Finance

  1. Bourse
  2. Insiders
  3. Simos Simeonidis